Here's why the CV Check (ASX:CV1) share price has soared 30% today

The CV Check Ltd (ASX: CV1) share price has rocketed 30% on a positive first quarter FY21 update to the market.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The CV Check Ltd (ASX: CV1) share price has surged today after the company updated the market with its first quarter FY21 performance. The news sent the CV Check share price surging to 15 cents, up 30%, before dropping back to 14 cents at the time of writing.

In comparison, the All Ordinaries Index (ASX: XAO) is up 0.4% at 6,191 points.

Chalk-drawn rocket shown blasting off into space

Image source: Getty Images

First quarter results

CV Check recorded a strong sales recovery, achieving a revenue of $3.4 million for the first quarter of the financial year. The 40% increase in revenue over the prior corresponding period (pcp) was a result of new client wins and recovering order flow from existing customers. CV Check's B2B segment came in at $2.6 million in earnings followed by $0.8 million in its B2C division.

The company also set a new sales record for the month of September, driven by record demand for total website users and new account sign ups over the 12 months.

Furthermore, the integration of CV Check with RealMe, a digital identity verification system, jumped 156% in sales on the pcp. The platform which is operated by the New Zealand government, continues to rise on the average number of checks per order.

CV Check reported it has no debt and a cash balance of $5.2 million as of September 30.

Notable new customers

CV Check welcomed new business customers to its growing list. The new additions include Amaysim Australia Ltd (ASX: AYS), the Australian Digital Health Agency, Sigma Healthcare Ltd (ASX: SIG), Village Roadshow Ltd (ASX: VRL) and others.

The company saw these new clients place their first orders, highlighting the strength of CV Check's range of screening and verification products.

What did management say

CV Check chief executive officer Rod Sherwood noted the company's resilience in the face of COVID-19. He said:

A resurgence of CV1 revenues was experienced during the past quarter with record sales being achieved for the month of September despite renewed shutdowns across New Zealand and Victoria.

Our team's agility was demonstrated in their effective, measured response to pandemic related developments in those geographies. New client wins were strong throughout the period before accelerating during September while sales to established customers recovered strongly.

CV Check share price summary

The CV Check share price has risen 326% since falling to its 52-week low of 4.6 cents in March. Although materially higher of late, the CV Check share price has barely moved since the start of the calendar year, up 3% after today's meteoric rise.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has recommended CV Check Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A panel of four judges hold up cards all showing the perfect score of ten out of ten
Share Gainers

Here are the top 10 ASX 200 shares today

It was a veritable party on the ASX today.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

ASX board.
Share Market News

ASX 200 charges higher again as relief rally gathers pace

The ASX 200 keeps climbing as global tensions begin to ease.

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why Dateline, Karoon Energy, Lindian, and PEXA shares are falling today

These shares are missing out on the good times on Wednesday. But why?

Read more »

Excited couple celebrating success while looking at smartphone.
Share Gainers

Why Arafura Rare Earths, Eagers Automotive, Life360, and Pro Medicus shares are racing higher today

These shares are having a good session on hump day. But why?

Read more »

A man slumps crankily over his morning coffee as it pours with rain outside.
Share Fallers

These were the worst-performing ASX 200 shares in March

These shares were out of form in March. Let's see why investors sold them off.

Read more »